Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Grant awarded to study gut-liver communication

Grant awarded to study gut-liver communication

Date time 22 October, 2025
News Type News type Research News
Associate Professors Patrick Bertolino and David Bowen
Associate Professor Patrick Bertolino, Head of the Centre for Infection & Immunity at the Centenary Institute, and Associate Professor David Bowen from the same centre, have been awarded a 2025 Gastroenterological Society of Australia (GESA) Project Grant. The $50,000 grant will support their study ‘Decoding Microbiome–Liver Communication via Portal Tracts.’

The project will explore how the gut microbiome, the bacteria and other microorganisms living in the digestive tract, sends signals to specialised areas of the liver known as portal tracts. These areas surround the large blood vessels of the liver and are rich in immune cells. As substances from the gut enter the liver through these portal tracts, the resident immune cells are among the first to be exposed to gut-derived microbial signals.

By uncovering how these gut signals influence liver immune responses, the research could lead to new ways to prevent or treat liver diseases such as non-alcoholic steatohepatitis (NASH), a severe form of fatty liver disease.

“Studies have shown that the gut microbiome influences liver disease outcomes, but the nature and mechanisms behind this communication remains a mystery,” said Associate Professor Bertolino.

“This grant will help us understand how immune cells in the liver respond to microbial signals. The knowledge we gain could open the door to new strategies for managing liver inflammation and disease.”

Associate Professor Bertolino says the study will use advanced imaging and molecular techniques, with the findings laying the groundwork for future research into gut and liver interactions and their impact on health more broadly.

People

  • Associate Professor Patrick Bertolino

    Head, Centre for Infection & Immunity

  • Associate Professor David Bowen

    Faculty

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • Vaxosome launched to develop next-generation mRNA vaccines

    A new biotechnology company, Vaxosome, has been launched to develop next-generation vaccines aimed at tackling some of the world’s most challenging infectious diseases.
    News Type: Research News
    Date 10 Mar 2026
  • Centenary partners in transformative national liver health program

    The Snow Medical Research Foundation has today announced major long-term funding of $15.5 million for a new national research program targeting fatty liver disease, a condition that affects up to one in three Australians. The Centenary Institute will play a key role in the collaborative effort.
    News Type: Research News
    Date 05 Mar 2026
  • Centenary exhibition brings medical research to life in hospital spaces

    The Centenary Institute’s 'When Art Meets Science' exhibition took centre stage at the recent launch of the annual Sydney Local Health District (SLHD) March Arts program.
    News Type: Community
    Date 04 Mar 2026
  • ‘Mini hearts’ show COVID-19 virus directly infects heart tissue

    Researchers from the Centenary Institute and the University of Technology Sydney (UTS) have developed a human heart cell model demonstrating that the virus that causes COVID‑19 (SARS-CoV-2) can directly infect heart tissue, providing new insight into why some people experience serious heart complications during and after infection.
    News Type: Media release
    Date 03 Mar 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram